Cx Institutional Takeda Pharmaceutical CO LTD Transaction History
Cx Institutional
- $3.29 Billion
- Q3 2025
A detailed history of Cx Institutional transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Cx Institutional holds 42 shares of TAK stock, worth $598. This represents 0.0% of its overall portfolio holdings.
Number of Shares
42
Previous 42
-0.0%
Holding current value
$598
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding TAK
# of Institutions
373Shares Held
77.8MCall Options Held
1.68MPut Options Held
157K-
Capital Research Global Investors Los Angeles, CA13.4MShares$191 Million0.04% of portfolio
-
Morgan Stanley New York, NY7.62MShares$109 Million0.01% of portfolio
-
Ubs Group Ag5.89MShares$83.9 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY4.5MShares$64.1 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.86MShares$55 Million0.08% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $44.3B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...